scispace - formally typeset
S

Saraswati Sukumar

Researcher at Johns Hopkins University School of Medicine

Publications -  262
Citations -  28255

Saraswati Sukumar is an academic researcher from Johns Hopkins University School of Medicine. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 77, co-authored 248 publications receiving 26027 citations. Previous affiliations of Saraswati Sukumar include Tufts University & Salk Institute for Biological Studies.

Papers
More filters
Journal Article

Post-translation regulation inhibits Claudin-7 expression in invasive breast cancer cells.

TL;DR: Preliminary data strongly suggest that a specific regulatory mechanism appear to be occurring at post-translational level in invasive and metastatic breast cancer cells to tightly control the expression of a specific Claudin protein.
Journal ArticleDOI

A prospective study of adjuvant anastrozole and gene promoter methylation in the contralateral breast of high-risk women

TL;DR: Postmenopausal women with hormone receptor-positive stage 0-III breast cancer who had completed local therapy, had an intact CLB, and would receive an AI as their sole adjuvant therapy were surveyed for the effect of anastrozole on breast density and circulating estrogens, and CLB gene methylation.
Proceedings ArticleDOI

Abstract P3-04-08: Expression of hormone-responsive genes in benign breast tissue varies with menstrual cycle phase and menopausal status

TL;DR: These hormone-responsive genes are candidate MCP classifiers which could be applied to archived breast samples to assess whether biomarkers of breast cancer risk are stable across the menstrual cycle, since MCP and MPS variation is likely an important source of biological noise in studies of archived breast biopsy material.
Journal ArticleDOI

ETS genes in breast cancer: A step in the right direction

TL;DR: Commentary to: Profile of Ets Gene Expression in Human Breast Carcinoma Jin He, Yong Pan, Jianhua Hu, Constance Albarracin, Yun Wu and Jia Le Dai
Journal ArticleDOI

Capturing ctDNA from Unaltered Stationary and Flowing Plasma with dCas9.

TL;DR: The goal was to develop the first technology that can capture ctDNA from flowing unaltered plasma and show that the capture rate using turbulent flow was greater than that in laminar flow and stationary plasma.